Pentamidine diisethionate

Authors:Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Chemotherapeutic agent, antiprotozoal.

Half-lifeThis section has been translated automatically.

Four days.

Pharmacodynamics (Effect)This section has been translated automatically.

Inhibition of dihydrofolate reductase, inhibition of RNA and protein synthesis.

Spectrum of actionThis section has been translated automatically.

Leishmania spp., Trypanosoma brucei gambiense (except cerebral stage), Pneumocystis carinii.

IndicationThis section has been translated automatically.

Prophylaxis of Pneumocystis carinii pneumonia in HIV patients with < 200 CD4 cells/μl, African tryposomiasis, leishmaniasis .

Dosage and method of useThis section has been translated automatically.

  • Visceral leishmaniasis that does not respond to antimony compounds: 4 mg/kg bw/day for 2 weeks or 4 mg/kg bw 3 times/week (until parasites are no longer detected in 2 spleen biopsies 2 weeks apart).
  • Cutaneous leishmaniasis (L. aethiopica, L. guyanensis): 3-4 mg/kg bw 1-2 times/week until the ulcers have healed
  • Mucocutaneous leishmaniasis (L. brasiliensis, L. aethiopica): 4 mg/kg bw 3 times/week until the ulcers have healed, possibly for several months.
  • Diffuse cutaneous leishmaniasis (L. aethiopica): 3-4 mg/kg bw/day for months, at least another 4 months until the smears have become negative.
  • Trypanosoma brucei spp.: 5 mg/kg bw/day for the 2nd day, 10 cycles in total.
  • Pneumocystis carinii pneumonia:
    • Prophylaxis: 200 mg/day for 4 days by inhalation, then 300 mg every 28 days.
    • Therapy: 4 mg/kg bw/day i.v. (over 60 min.) for 14 days, then 300-600 mg/day.

Undesirable effectsThis section has been translated automatically.

hypotension, hypertension, vomiting, kidney failure, hypo- and hyperglycaemia, pancreatic necrosis, BB changes, liver damage, shock, rarely Herxheimer's reaction, allergic reactions, contact eczema, erythroderma

InteractionsThis section has been translated automatically.

See Table 2.

ContraindicationThis section has been translated automatically.

Pregnancy, kidney dysfunction.

PreparationsThis section has been translated automatically.

Pentacarinate

TablesThis section has been translated automatically.

Essential interactions of pentamidine diisethionate

amphotericin B

Nephrotoxicity ↑

Erythromycin

Cardiac arrhythmia

Foscarnet

Hypocalcemia, nephrotoxicity ↑

Ganciclovir

Haematotoxicity ↑

Zalcitabine

Pancreatitis ↑

Zidovudine

Haematotoxicity ↑

Authors

Last updated on: 29.10.2020